American Century Companies Inc Argenx Se Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Argenx Se stock. As of the latest transaction made, American Century Companies Inc holds 231,909 shares of ARGX stock, worth $148 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

231,909

Previous 254,363 8.83%

Holding current value

$148 Million

Previous $109 Million 14.98%

% of portfolio

0.08%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$434.22 - $551.9 $9.75 Million - $12.4 Million	-22,454 Reduced 8.83%	231,909 $126 Million
Q2 2024 Aug 07, 2024	SELL	$356.01 - $451.55 $520,842 - $660,617	-1,463 Reduced 0.57%	254,363 $109 Million
Q1 2024 May 14, 2024	BUY	$356.95 - $413.29 $35.7 Million - $41.4 Million	100,145 Added 64.33%	255,826 $101 Million
Q4 2023 Feb 13, 2024	BUY	$338.91 - $506.01 $52.8 Million - $78.8 Million	155,681 New	155,681 $59.2 Million
Q3 2023 Nov 13, 2023	SELL	$369.35 - $548.43 $2.33 Million - $3.46 Million	-6,303 Reduced 3.4%	178,842 $87.9 Million
Q2 2023 Aug 14, 2023	SELL	$360.14 - $422.58 $7.63 Million - $8.95 Million	-21,189 Reduced 10.27%	185,145 $72.2 Million
Q1 2023 May 11, 2023	SELL	$334.23 - $403.65 $2.22 Million - $2.68 Million	-6,647 Reduced 3.12%	206,334 $76.9 Million
Q4 2022 Feb 13, 2023	SELL	$342.17 - $402.31 $1.58 Million - $1.86 Million	-4,622 Reduced 2.12%	212,981 $80.7 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $2.85 Million - $3.29 Million	-8,307 Reduced 3.68%	217,603 $76.8 Million
Q2 2022 Aug 12, 2022	SELL	$269.58 - $378.88 $994,480 - $1.4 Million	-3,689 Reduced 1.61%	225,910 $85.6 Million
Q1 2022 May 11, 2022	BUY	$254.45 - $351.06 $532,309 - $734,417	2,092 Added 0.92%	229,599 $72.4 Million
Q4 2021 Feb 07, 2022	BUY	$272.01 - $353.03 $775,500 - $1.01 Million	2,851 Added 1.27%	227,507 $79.7 Million
Q3 2021 Nov 10, 2021	SELL	$295.0 - $350.58 $54.7 Million - $65 Million	-185,455 Reduced 45.22%	224,656 $67.8 Million
Q2 2021 Aug 05, 2021	BUY	$257.11 - $319.92 $760,531 - $946,323	2,958 Added 0.73%	410,111 $123 Million
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $362,205 - $513,418	1,350 Added 0.33%	407,153 $112 Million
Q4 2020 Feb 12, 2021	SELL	$248.13 - $308.36 $4.5 Million - $5.59 Million	-18,140 Reduced 4.28%	405,803 $119 Million
Q3 2020 Nov 13, 2020	SELL	$215.51 - $272.51 $7.21 Million - $9.11 Million	-33,442 Reduced 7.31%	423,943 $111 Million
Q2 2020 Aug 13, 2020	BUY	$127.44 - $232.72 $12 Million - $21.9 Million	94,074 Added 25.89%	457,385 $103 Million
Q1 2020 May 14, 2020	BUY	$108.83 - $165.23 $931,149 - $1.41 Million	8,556 Added 2.41%	363,311 $47.9 Million
Q4 2019 Feb 12, 2020	BUY	$106.59 - $164.21 $22.9 Million - $35.2 Million	214,593 Added 153.1%	354,755 $56.9 Million
Q3 2019 Nov 13, 2019	BUY	$113.31 - $150.51 $7.5 Million - $9.96 Million	66,168 Added 89.42%	140,162 $16 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $8.51 Million - $10.5 Million	73,994 New	73,994 $10.5 Million

Others Institutions Holding ARGX

# of Institutions

401

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Argenx Se Transaction History